Literature DB >> 11274584

Hyperhemolytic transfusion reaction in sickle cell disease.

N Win1, H Doughty, P Telfer, B J Wild, T C Pearson.   

Abstract

BACKGROUND: An atypical form of life-threatening hemolytic transfusion reaction (HTR) in patients with sickle cell disease (SCD) has been well described in the literature. Continuation of blood transfusion may be lethal, as it can further exacerbate hemolysis. The pathophysiologic mechanism of HTR is not well understood. CASE REPORTS: Two cases of severe HTR in SCD after the transfusion of compatible RBC units are reported. Hemolysis of both autologous and transfused cells was documented in Case 1 by urine Hb high-performance liquid chromotography. Multispecific HLA antibodies were identified in Case 1. Reticulocytopenia was noted in both cases during the acute hemolytic process. This was followed by a rise in reticulocyte count during receipt of IVIG and steroid therapy. Bone marrow examination during reticulocytopenia in Case 2 showed erythroid hyperplasia.
CONCLUSION: In SCD, both mature sickle cells and sickle reticulocytes adhere more readily to macrophages. In view of the bone marrow aspiration results, it appears that the recipients' HbS cells are destroyed by hyperactive macrophages and that the reticulocytopenia observed during HTR is likely to be due to peripheral consumption (i.e., destruction by macrophages), rather than suppression of erythropoiesis. Cessation of hemolysis during IVIG and steroid treatment may be due to IVIG's blocking of the adhesion of sickle cells and reticulocytes to macrophages, together with steroid suppression of macrophage activity.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11274584     DOI: 10.1046/j.1537-2995.2001.41030323.x

Source DB:  PubMed          Journal:  Transfusion        ISSN: 0041-1132            Impact factor:   3.157


  21 in total

1.  Fatal Delayed Haemolytic Transfusion Reaction and Hyperhaemolysis Syndrome in a Pregnant Woman with Sickle Cell Anaemia.

Authors:  Asral Wirda Ahmad Asnawi; Jameela Sathar; Rashidah Mohamed; Rohayu Deraman; Sri Kumaran; Shahada Sobah Abd Hamid; Muhd Zanapiah Zakaria
Journal:  Indian J Hematol Blood Transfus       Date:  2015-01-01       Impact factor: 0.900

Review 2.  Genetically-engineered pigs as sources for clinical red blood cell transfusion: What pathobiological barriers need to be overcome?

Authors:  Benjamin Smood; Hidetaka Hara; Leah J Schoel; David K C Cooper
Journal:  Blood Rev       Date:  2019-01-28       Impact factor: 8.250

3.  Fatal delayed transfusion reaction in a sickle cell anemia patient with Serratia marcescens sepsis.

Authors:  Desiree Seeyave; Ninad Desai; Scott Miller; Sreedhar P Rao; Steve Piecuch
Journal:  J Natl Med Assoc       Date:  2006-10       Impact factor: 1.798

4.  Delayed hemolytic transfusion reaction in children with sickle cell disease.

Authors:  Mariane de Montalembert; Marie-Dominique Dumont; Claire Heilbronner; Valentine Brousse; Oussama Charrara; Béatrice Pellegrino; Christophe Piguet; Valérie Soussan; France Noizat-Pirenne
Journal:  Haematologica       Date:  2011-02-17       Impact factor: 9.941

Review 5.  Delayed hemolytic transfusion reaction in sickle cell disease.

Authors:  Leslie P Scheunemann; Kenneth I Ataga
Journal:  Am J Med Sci       Date:  2010-03       Impact factor: 2.378

6.  Clinical strategies for supporting the untransfusable hemorrhaging patient.

Authors:  Gavin M Melmed; Meredith E Hulsey; Mike Newhouse; Houston E Holmes; Edward J Mays
Journal:  Proc (Bayl Univ Med Cent)       Date:  2009-10

Review 7.  Beyond the definitions of the phenotypic complications of sickle cell disease: an update on management.

Authors:  Samir K Ballas; Muge R Kesen; Morton F Goldberg; Gerard A Lutty; Carlton Dampier; Ifeyinwa Osunkwo; Winfred C Wang; Carolyn Hoppe; Ward Hagar; Deepika S Darbari; Punam Malik
Journal:  ScientificWorldJournal       Date:  2012-08-01

8.  Fatal delayed haemolytic transfusion reaction in a patient without previous transfusions but with an obstetric history of 13 pregnancies.

Authors:  Evgeni Chubar; Naiel Bisharat
Journal:  BMJ Case Rep       Date:  2017-11-03

Review 9.  Red blood cell alloimmunization in sickle cell disease: pathophysiology, risk factors, and transfusion management.

Authors:  Karina Yazdanbakhsh; Russell E Ware; France Noizat-Pirenne
Journal:  Blood       Date:  2012-05-04       Impact factor: 22.113

10.  Hyperhemolysis in a patient with beta-thalassemia major.

Authors:  Lakmali R Morawakage; B J C Perera; P D N Dias; S K Wijewardana
Journal:  Asian J Transfus Sci       Date:  2009-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.